Manchester Science Partnerships has announced that work has started on Citylabs 2.0
The first phase of Manchester Science Partnerships (MSP) £60 million extensions of the Citylabs campus, which will be at the heart of Greater Manchesters new globally-leading genomics campus for innovation, precision medicine, translational science, and molecular diagnostics is starting to take shape.
Located within Europe’s largest clinical-academic campus, Citylabs 2.0 is surrounded by the Manchester Royal Infirmary, Royal Manchester Children’s Hospital, Saint Mary’s Hospital and Manchester Royal Eye Hospital and will build on the success of Citylabs 1.0 which has been fully let since its completion in 2015 and has already showcased a unique new way of collaborative working between industry, academia and clinicians.
Principal contractor Sir Robert McAlpine has been awarded the £22m contract for the 92,000 sq ft development, a Joint Venture partnership between MSP and Manchester University NHS Foundation Trust (MFT) which is due for completion by the end of 2020.
Designed by architects Sheppard Robson, Citylabs 2.0 has been pre-let to global molecular diagnostics company QIAGEN and will become its European Hub for Diagnostics Development. QIAGEN’s expansion and relocation from their existing base at Manchester Science Park will see them become the anchor industrial partner in the global genomics campus where they will connect in with a diverse community of businesses including those working in MedTech, clinical trials, data management, and will gain access to the MFT’s specialist clinical resources and expertise from researchers, clinicians and procurement teams.
Manchesters new genomics campus will create more than 1,500 high-value jobs over the next decade, adding over £150m to our city’s economy. Crucially, it will positively impact the lives of over three million people by providing access to new diagnostics and more targeted treatments through pioneering research and will see these products and services adopted into the city’s health service at a much faster rate.